Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 749, pseudogene (RNU6-749P) is a human pseudogene derived from sequences homologous to the U6 small nuclear RNA genes, which are involved in RNA splicing as part of the spliceosome complex[5][3]. RNU6-749P is classified as a non-protein-coding pseudogene and is located on chromosome 15 (GRCh38, reverse strand)[5]. Like other pseudogenes, it is generally considered nonfunctional in terms of protein coding, but it may potentially have regulatory roles at the RNA level by acting as a long non-coding RNA or through competing endogenous RNA (ceRNA) mechanisms, although there is no direct functional evidence for this particular pseudogene[4][6]. There is currently no evidence that RNU6-749P is involved in human disease, serves as a biomarker, or is targeted by any drugs[1][5][7].
Not applicable. No drugs or therapeutic approaches target pseudogenes like this specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 749, pseudogene (RNU6-749P).